相关实验视频
Updated: Jun 30, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.5K
CFSSynergy:结合基于特征和基于相似性的方法来预测药物协同作用.
Fatemeh Rafiei1, Hojjat Zeraati1, Karim Abbasi2
1Department of Epidemiology and Biostatistics, School of Health, Tehran University of Medical Sciences, Tehran 14167-53955, Iran.
Journal of chemical information and modeling
|March 22, 2024
概括
通过使用一种新的计算方法,CFSSynergy通过准确预测药物协同作用来增强癌症治疗. 这种方法结合了基于特征和相似性的技术,比现有的药物协同效应预测模型具有更高的性能.
科学领域:
- 计算生物学是一种计算生物学.
- 生物信息学是一种生物信息学.
- 药物发现 药物发现
背景情况:
- 药物协同作用预测对于有效的癌症治疗至关重要.
- 实验方法是昂贵和耗时的,推动了对计算方法的需求.
- 现有的计算方法要么基于特征,要么基于相似性,都有局限性.
研究的目的:
- 提出一种新的混合计算方法,CFSSynergy,用于预测药物协同作用.
- 整合基于特征和基于相似性的方法,以提高预测准确度.
- 开发一个强大的模型来识别在癌症治疗中协同作用的药物组合.
主要方法:
- 使用基于变压器的架构来表示药物.
- 使用Node2Vec算法创建蛋白质-蛋白质相似性矩阵用于细胞系表示.
- 集成学习特征与基于相似性的特征,并使用XGBoost进行预测.
主要成果:
- 与现有方法相比,CFSSynergy在DrugCombDB和OncologyScreen数据集上表现出优越的性能.
- 拟议的方法有效地捕捉了药物和细胞系之间的复杂协同相互作用.
- 混合方法显著提高了药物协同效应预测的准确性.
结论:
- CFSSynergy为药物协同效应预测提供了一个强大而准确的计算工具.
- 多种特征类型的整合增强了模型识别有效药物组合的能力.
- 这种方法对推进个性化癌症治疗具有重大前景.
相关概念视频
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Agonism and Antagonism: Quantification
368
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
368
Combined Effects of Drugs: Antagonism
8.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K

